688075.SH
安旭生物
SSE · Healthcare · Medical - Specialties · CN
CNY 29.08
−1.59%Margins
Gross margin
42.3%
EBITDA margin
29.7%
EBIT margin
5.1%
Net margin
6.1%
FCF margin
-22.3%
0.5%
Return on equity
0.4%
Return on assets
0.4%
Return on invested capital
0.07x
Asset turnover
-CNY 1.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026